Revenue First, Science Second - Manager Castle Biosciences Employee Review

1.0
8 June 2026
Recommend
CEO approval
Business outlook

Pros

Compensation and benefits were competitive.

Cons

The company culture heavily prioritizes the sales organization over nearly every other department. Business decisions often appear driven by revenue generation and test adoption rather than collaboration across functions or broader healthcare objectives. Employees outside of sales may feel their contributions are undervalued compared to those directly tied to sales performance. Leadership culture can feel insular, with many key positions occupied by individuals who have longstanding personal, family, or social connections within the organization. This can create a perception that advancement, accountability, and decision-making are not always applied consistently across employees. Tenure appears to carry significant weight in promotion decisions, sometimes resulting in leadership roles being filled by individuals with limited management experience outside of the company or limited healthcare industry experience. Employees who value scientific rigor, evidence-based decision-making, and open debate may find the culture frustrating. Individuals who are comfortable accepting established narratives without questioning them are likely to have a more positive experience. Constructive challenges to existing processes, products, or strategies are often met with resistance rather than genuine evaluation. A recurring concern was the organization's response to quality and process issues. For example, duplicate tests could be run on the same patient and produce differing results, raising questions about consistency and reliability. Rather than prioritizing process improvements to prevent duplicate testing or investing in efforts to better understand and address result variability, the response often appeared focused on adjusting employee performance metrics and operational targets. Opportunities to introduce data-driven improvements can be limited, particularly when proposed changes conflict with existing leadership priorities or established reputations. In my experience, there was greater emphasis on maintaining productivity and business objectives than on openly addressing concerns about test reproducibility, operational inefficiencies, or opportunities to strengthen confidence in the product itself. For a company operating in healthcare, I would have expected a stronger commitment to ensuring test accuracy, consistency, clinical reliability, and meaningful patient impact before focusing on growth and adoption. Employees seeking an environment where evidence, critical thinking, transparency, and continuous improvement consistently drive decision-making may find the culture misaligned with those expectations.

Explore other reviews about Castle Biosciences

5.0
15 June 2026
Recommend
CEO approval
Business outlook

Pros

The company culture is unparalleled. Not only is the company making a difference in patients lives, it also cares deeply for the employees. We are growing and with growing comes some change.

Cons

None, it is truly a collaborative work environment.

1.0
2 June 2026
Recommend
CEO approval
Business outlook

Pros

The company really sells a good solution to patients.

Cons

I can see that this company is passionate about medicine. However, this company is nothing but false propaganda. They bombard you with the idea that you matter but in actuality it is all performative buzzwords. They blow smoke up your backside and then back stab you whenever they see convenient. The managers are passive aggressive and the training is unstructured. Nepotism is huge here so be careful and watch your back. I want whoever that reads this to really not fall for the propaganda and fake smiles because these people are not who they say they are.

1
See reviews by: Helpful|Rating|Date|All